Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5Z5Q

Nukacin ISK-1 in active state

5Z5Q の概要
エントリーDOI10.2210/pdb5z5q/pdb
NMR情報BMRB: 36157
分子名称Lantibiotic nukacin (1 entity in total)
機能のキーワードlantibiotics, antibiotic
由来する生物種Staphylococcus warneri
タンパク質・核酸の鎖数1
化学式量合計2970.53
構造登録者
Kohda, D.,Fujinami, D. (登録日: 2018-01-19, 公開日: 2018-11-28, 最終更新日: 2024-07-10)
主引用文献Fujinami, D.,Mahin, A.A.,Elsayed, K.M.,Islam, M.R.,Nagao, J.I.,Roy, U.,Momin, S.,Zendo, T.,Kohda, D.,Sonomoto, K.
The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states.
Commun Biol, 1:150-150, 2018
Cited by
PubMed Abstract: The lantibiotic nukacin ISK-1 exerts antimicrobial activity through binding to lipid II. Here, we perform NMR analyses of the structure of nukacin ISK-1 and the interaction with lipid II. Unexpectedly, nukacin ISK-1 exists in two structural states in aqueous solution, with an interconversion rate on a time scale of seconds. The two structures differ in the relative orientations of the two lanthionine rings, ring A and ring C. Chemical shift perturbation induced by the titration of lipid II reveals that only one state was capable of binding to lipid II. On the molecular surface of the active state, a multiple hydrogen-bonding site formed by amino acid residues in the ring A region is adjacent to a hydrophobic surface formed by residues in the ring C region, and we propose that these sites interact with the pyrophosphate moiety and the isoprene chain of the lipid II molecule, respectively.
PubMed: 30272026
DOI: 10.1038/s42003-018-0150-3
主引用文献が同じPDBエントリー
実験手法
SOLUTION NMR
構造検証レポート
Validation report summary of 5z5q
検証レポート(詳細版)ダウンロードをダウンロード

252816

件を2026-04-29に公開中

PDB statisticsPDBj update infoContact PDBjnumon